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It is well known that high density lipoprotein (HDL) binds bacterial lipopolysaccharide (LPS) and neutralizes its
toxicity. The aim of this work was to study changes in the apolipoprotein (apo) AI structure after its interaction with
LPS as well as to determine the protein domain involved in that interaction. The presented data indicate that LPS does
not lead to major changes in the structure of apoAI, judging from Trp fluorescence spectra. However, analysis of
denaturation behavior and binding of ANS show that LPS induces a loosened protein conformation. Further evidence
for an apoAI–LPS specific interaction was obtained by incubation of the protein with 125I-ASD-LPS. The results show
that multiple regions of the protein were able to interact with LPS, according to its amphiphatic nature. Finally, the
contribution of the purified C-terminal fragment of the protein in the endotoxin neutralization was evaluated in
comparison with the effect of apoAI. In both cases, the same decrease in tumor necrosis factor-a released was
observed. This result suggests that the C-terminal half of apoAI is the main domain responsible of the neutralization
effect of this protein. Our data may provide innovative pharmacological tools in endotoxin neutralization therapies.
Keywords: lipoprotein, TNF-alpha, ASD-LPS, ANS, GdnHCl denaturation
Abbreviations: apolipoprotein (apo) AI, apoAI; LPS, lipopolysaccharide; SASD, sulfosuccinimidyl 2-(-azidosalicy-
lamido)-1,30-dithiopropionate; ASD, 2-(p-azidosalicylamido)-1,30-dithiopropionate; ASD-LPS, ASD-coupled LPS;
125I-ASD-LPS, 125I-iodinated ASD-LPS; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline
(pH 7.2); SDS, sodium dodecyl sulfate. ANS, 1-anilino-naphthalene-1,3,5-sulfonate; rHDL, reconstituted high density
lipoprotein; LUV, large unilamellar vesicle; NBS, N-bromosuccinimide; POPC, 1-palmitoyl-2-oleyl phosphatidyl-
choline; Trp, tryptophan; CD, circular dichroism; TNF-a, tumor necrosis factor-a
INTRODUCTION
Lipopolysaccharide (LPS), the toxic component present
in the outer membrane of Gram-negative bacteria, is the
major pathogenic factor in sepsis. When LPS enters the
blood-stream, it elicits inflammatory responses that may
lead to septic shock and, ultimately, death.
Wu et al.1 reported that high-density lipoproteins
(HDL) might possess anti-inflammatory properties and
play a crucial role in innate immunity by regulating the
inflammatory response as well as reducing the severity
of organ injury in animals and patients with septic shock
via LPS-binding and neutralization.
However, HDL has been shown to be substantially
reduced as part of an acute-phase response to infections
and the magnitude of this reduction is positively corre-
lated with the severity of illness.2,3 In the acute-phase
response, plasma HDL changes from anti-inflammatory
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to pro-inflammatory,4 which may render the patient
more susceptible to pro-inflammatory stimuli. The
mechanisms underlying this phenomenon are poorly
understood, although increased levels of several acute-
phase proteins, including serum amyloid A (SAA) and
secretory phospholipase A2 (sPLA2) may contribute to
the decrease in plasma HDL.
Studies in humans demonstrated that the LPS-induced
production of tumor necrosis factor (TNF)-a in blood
samples, taken from critically ill patients, was reduced
by the supplementation of a reconstituted HDL (rHDL)
preparation.5
Several studies indicate that the anti-endotoxin func-
tion of HDL is due to the interaction between the lipid
portion of the LPS molecule and phospholipid in HDL.6
Previous evidence from our laboratory (Henning et al.,
unpublished results) shows that incubation of LPS with
liposomes decreases the amount of TNF-a released from
RAW cells. However, other authors reported that apoAI
might be the major neutralizing factor,7,8 instead of HDL
lipids.
Apolipoprotein (apo) AI, the major protein compo-
nent of serum HDL, has an amphipathic a-helical
structure. The lipid binding sites on the amphipathic
a-helix may be the domain involved in the interaction with
LPS via the lipid A moiety. Thus, apoAI should be a safe
and effective treatment to prevent or reverse the conse-
quences of endotoxemia and tissue inflammatory injury.
The direct inactivation of endotoxin effect by free
apoAI was demonstrated by Emancipator et al.9 in
in vitro studies. More recently, Yan et al.10 observed that
apoAI could: (i) attenuate LPS-induced acute lung injury
and inflammation; (ii) significantly inhibit LPS-induced
inflammatory cytokine levels in serum; (iii) inhibit
L-929 cell death induced by LPS-activated macrophages
in a dose-dependent fashion; and (iv) significantly
decrease the mortality of mice with endotoxemia.
Furthermore, Ma et al. showed that apoAI inhibited
macrophage activation when the protein was pre-
incubated with LPS. Also, they observed that apoAI
binds LPS indirectly by LPS binding protein (LBP),
albeit it can bind LPS directly and neutralize its
cytotoxicity.11
The molecular understanding of the LPS neutraliza-
tion process by apoAI requires knowledge of the
molecular conformation of lipid-free apoAI and the
conformational changes that it suffers after binding
to LPS.
In this context, the purpose of this study was to
investigate the effects of LPS on the structure of apoAI
and characterize the apoAI domain involved in this
interaction. In this research, we show data about the
neutralization of the endotoxic LPS effects by the
C-terminal end of apoAI.
MATERIALS AND METHODS
Protein purification
Apolipoprotein AI was purified from the HDL fraction of
human serum (kindly donated by the Banco de Sangre del
Instituto de Hemoterapia de la Provincia de Buenos Aires,
La Plata, Argentina) according to the procedure previously
described,12 and stored in lyophilized form at 70C.
Before each experiment, apoAI was solubilized in 3 M
guanidinium hydrochloride (GdnHCl) and dialyzed exten-
sively against buffer A (10 mM Tris, 150 mM NaCl, 1 mM
EDTA, 1 mM NaN3, pH 8.0; 1 : 2000, v : v) for 18 h at 4
C.
Apolipoprotein AI–LPS interaction
Lipopolysaccharide (LPS) from Escherichia coli
O111:B4 was purchased from Sigma Aldrich (St
Louis, MO, USA).
For all experiments, apoAI (2.85 mmol) was incubated
with LPS (1 : 2.8, molar ratio) at 25C for 15 min in
buffer A. The molecular mass taken for LPS was of
10 kDa, according to Aurell and Winstrom.13
Fluorescence spectroscopy
Protein intrinsic fluorescence spectra were recorded on a
Perkin-Elmer LS 50B spectrofluorimeter with a tem-
perature-controlled sample holder. The excitation wave-
length used was 295 nm to minimize tyrosine
emission.14 Fluorescence was measured after incubating
apoAI with LPS. Spectra were recorded in the range
320–400 nm using 150-ml cuvettes (4 nm slit width for
both excitation and emission).
Chemical modification of apoAI with
N-bromosuccinimide (NBS)
A freshly prepared solution of NBS was added to apoAI
or apoAI–LPS mixture to achieve NBS:Trp molar ratios
ranging from 0.25 : 1 to 2 : 1. (mol : mol).15 After equil-
ibrating for 10 min, the Trp emission spectra were
recorded in the wavelength range 300–400 nm. The
excitation wavelength used was 295 nm and fluores-
cence measurements were corrected for any dilution
factor.
Fluorescence of ANS
Fluorescence spectra of 8-anilino-1-naphthalenesulfonic
acid (ANS) were obtained in buffer A and in the
presence of apoAI or apoAI–LPS. Since ANS fluores-
cence in buffer is negligible,16 spectra were recorded in
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an excess of ANS (100mM) with respect to protein (mol
per mol). Samples were excited at 395 nm with emission
monitored from 400 to 600 nm (4 nm slit width for both
excitation and emission).
Guanidinium hydrochloride denaturation
Fluorescence emission of Trp was used to monitor apoAI
denaturation at increasing concentrations of GdnHCl, in
the absence and presence of LPS. Chemical stability was
measured after incubating apoAI or apoAI–LPS at
various GdnHCl concentrations (0–5.5 M), buffered
with buffer A at 25C for 2 h. After incubation, the
Trp fluorescence spectra were recorded in the range
320–400 nm using 150-ml cuvettes. The fluorescence
intensity at 333 nm was used to calculate fD (molar
fraction of denatured molecules)17 as follows:
fD ¼ Xx XGdnHCl 0 M=XGdnHCl 5:5 M  XGdnHCl 0 M ð1Þ
where Xx is the fluorescence intensity at 333 nm at each
GdnHCl concentration tested.
Far-UV circular dichroism spectroscopy
Spectra were recorded on a Jasco J-810 spectropolari-
meter. Data in the far-UV (190–250 nm) region were
collected using a 1-mm path cuvette. The sample
chamber was maintained at 25C. A scan speed of
20 nm/min with a time constant of 1 s was used. ApoAI
or apoAI–LPS (0.1 mg/ml protein concentration) were
dissolved in 50 mM sodium phosphate, pH 7.0.
Each spectrum was measured at least three times, and
the data were averaged to reduce noise. Molar ellipticity
was calculated as described elsewhere, using mean
residue weight values of 114.45 for apoAI.18 The
a-helix content of apoAI or apoAI–LPS was calculated
as described by Chen et al.19
Synthesis of ASD–LPS
Synthesis of 2-(p-azidosalicylamido)-1,30-dithiopropio-
nate (ASD)-LPS was done as described by
Wollenweber,20 with some modifications. Briefly, 1.5 ml
of E. coli O111: B4 LPS (2 mg/ml) in 5 mM EDTA pH
7.4, was mixed with 1.5 ml of 0.1 M borate pH 8.5. Six
milligrams of sulfosuccinimidyl 2-(p-azidosalicylamido)-
1,30-dithiopropionate (SASD, Pierce Chemical Co.) were
added to LPS-borate and the solution was briefly soni-
cated (model W-375, Ultrasonics); then, the reaction
mixture was kept at 20C for 30 min. An additional
incubation with 6 mg of fresh SASD was done under the
described conditions. Lipopolysaccharide coupled to
ASD–LPS was centrifuged to pellet remains of SASD
(2000 g for 2 min) followed by dialysis of the cleared
supernatant against 50 mM HEPES, 5 mM EDTA pH 7.4,
at 4C (minimum six changes), aliquoted (250ml), and
stored at 20C.
All reactions with photosensitive compounds were
carried out under reduced lighting using a 25-W red light
source.
Radio-iodination of ASD–LPS
Iodination of ASD–LPS was carried out according to
Ulevitch21 with minor modifications. Carrier-free Na125I
(5 mCi in 14 ml of 0.1 M NaOH; NEN Perkin Elmer) was
added to 250 ml of ASD–LPS in the presence of 50 ml of
0.1 mg/ml chloramine-T (Sigma) in freshly prepared
5 mM EDTA pH 7.4, and left for 5 min at 20C. The
reaction was stopped with 50 ml of 0.1 mg/ml sodium
metabisulfate freshly prepared in 5 mM EDTA pH 7.4.
The reaction mixture was dialyzed extensively against
50 mM HEPES, 5 mM EDTA pH 7.4, at 4C until less
than 0.5% of total radioactivity could be measured in the
outer dialysate. The 125I-ASD–LPS was collected and its
radioactivity checked. The LPS concentration of this
sample was determined by the 3-deoxy-D-manno-oct-
2-ulosonic acid content employing a colorimetric
microassay.22
Cross-linking of apoAI-125I-ASD–LPS
Five microlitres of 125I-ASD–LPS containing approxi-
mately 5 mg of LPS were incubated in the presence of
apoAI in borosilicate glass tubes for 1 h in a 25C water
bath. Samples subjected to photolysis were irradiated for
1 min with short-wave UV light with a Xenon lamp
(450 W) at a distance of 25 cm.
Sodium dodecyl sulfate-gel electrophoresis sample
buffer was added to a final concentration of 62.5 mM
Tris-HC1, pH 6.8, 3% SDS, 10% glycerol, 0.02%
bromophenyl blue, with or without 0.1 M dithioerythri-
tol. Approximately equal aliquots of radioactivity were
applied onto SDS-PAGE, and electrophoresis was car-
ried out according to Laemmli23 on 4–25% continuous
gradient gels. Proteins were stained with Coomassie
Blue R250 (Sigma) and destained with several washes
(5–6 times) in water/methanol/acetic acid (50 : 40 : 10,
v : v : v) at 20C, including 3.5% glycerol in a final
soaking. Gels were dried on a Slab Gel Dryer (Bio-Rad)
and subsequent autoradiography was performed on a
scanner model Storm 840.
Chemical cleavage of apoAI-125I-ASD–LPS with CNBr
For cleavage of apoAI-125I-ASD–LPS with CNBr, pro-
tein was dissolved in 50 ml of 70% formic acid, and
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CNBr was added in a 30 : 1 CNBr : protein w/w ratio and
incubated at 25C under a N2 atmosphere for 24 h. Then
the samples were dried in a Speed Vac system and
redissolved in 20 ml of sample buffer for tricine SDS-
PAGE analysis. Sodium dodecyl sulfate-PAGE was
carried out according to Scha¨gger24 in 17% acrylamide
Tris-tricine gel. After fixing with methanol : acetic
(50 : 10 v : v), the gel was stained with 0.025%
Coomassie Blue R250 in 10% acetic acid. Gels were
dried and exposed to X-Omat film (Kodak) for different
times depending on the amount of radioactivity.
N-Terminal sequencing of apoAI fragments
Peptide fragments obtained by CNBr proteolysis were
transferred from tricine-SDS-PAGE to polyvinylidene
difluoride (PVDF) membranes using a Trans-Blot semi-
dry transfer cell (Bio-Rad) at 100 V for 40 min.
N-Terminal sequencing was performed on the bands in
PVDF membranes using Edman method by the
Laboratorio Nacional de Investigacio´n y Sevicio en
Pe´ptidos y Proteı´nas (LaNaIS Pro, Universidad de
Buenos Aires-Consejo Nacional de Investigaciones
Cientı´ficas y Te´cnicas, Buenos Aires, Argentina).
Electroelution
After CNBr proteolysis of apoAI, the proteolytic prod-
ucts were separated by electrophoresis on Tris-tricine
gels and then the fragment of interest (C-terminal) was
isolated from the gels by electroelution using BioRad
equipment.25,26 After electroelution, the sample was
concentrated and checked by tricine SDS-PAGE. The
fragment concentration was determined by the method
of Lowry et al.27
Tumor necrosis factor- release measurements
With the aim to study if apoAI and C-terminal fragment
neutralize the endotoxic effect of LPS, macrophages
from the cell line RAW 264.7 were exposed to LPS or
apoAI/C-terminal fragment : LPS mixtures and the TNF-a
released was quantified. The ratios used were 1 : 1 and
1 : 10 w/w LPS to apoAI or C-terminal fragment. For cell
stimulation, the cultures were incubated, with LPS or
apoAI/fragment-LPS mixtures at a LPS final concentra-
tion of 10 ng/ml, for 4 h at 37C under 5% CO2. After
10-min centrifugation at 400 g, supernatants were col-
lected, fractioned and stored at 20C until their use for
the immunological determination of TNF-a by a sand-
wich ELISA method using BD OptEIA kit. All exper-
iments were carried out three times. Data were expressed
as mean SE and analyzed using Student’s t-test (Instat
2.0 Graph Pad Software, San Diego, CA, USA).
RESULTS
Steady-state fluorescence spectroscopy of lipid-free
apoAI and apoAI–LPS
Apolipoprotein AI has four Trp residues located in the
amino-terminal portion of the protein (residues 8, 50, 72
and 108) and their fluorescence is sensitive to the
environment. We proceeded to study the fluorescence
properties of apoAI in its lipid-free form and after its
incubation with LPS.
The wavelength of maximum fluorescence (max)
indicates the polarity of the Trp environment. Burstein
et al.28 classified Trp residues depending on the max-
imum ranges as follows: class I (330–332 nm), buried in
non-polar regions of protein; class II (340–342 nm),
surface but limited solvent contact; and class III (350–
352 nm), completely solvent exposed.
Concerning the lipid-free apoAI in buffer A, it
exhibits a max of 336 nm that represents the average
environment of all the Trp residues in the protein. After
its incubation with LPS, max was red-shifted about
0.5–1 nm, indicating that Trp exists in the free form,
located in a minimally solvent exposed environment.
The fluorescence spectra of apoAI in the lipid-free form
and its complex with LPS are shown in Figure 1.
Although no changes in the max of Trp spectra was
observed, there is an important decrease in the intrinsic
fluorescence intensity of apoAI after LPS addition.
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Fig. 1. Steady-state fluorescence spectroscopy of lipid-free apoAI (black
line) and LPS-bound apoAI (gray line). The emission spectra (300–
400 nm) were measured at 25C and the excitation wavelength used was
295 nm. Protein concentration used in both cases was 2.85 mM. ApoAI–
LPS (1 : 2.8 molar ratio) were previously incubated for 15 min.
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Chemical modification of Trp with N-bromosuccinimide
To determine precisely the relative exposure of each Trp
residue to LPS, apoAI was subjected to oxidation with
N-bromosuccinimide (NBS). Experiments were per-
formed at neutral pH to increase the specificity for Trp
residues. Under these conditions, the reaction of NBS
with Trp in apoAI is almost accomplished within 10 min
of incubation (data not shown).
As shown in Figure 2, fluorescence decreases approx-
imately 50% in both free and LPS-bound apoAI
suggesting, that some of the Trp residues are completely
protected from solvent. The max and NBS oxidation
data show that all Trp residues are surface located but
with limited solvent contact. No differences were
observed in the oxidation of Trp in presence of LPS.
So, the results suggest that the N-terminal half of apoAI,
where the Trp residues are located, is not involved in its
LPS interaction.
8-Anilino-1-naphthalenesulfonic acid (ANS)
binding experiments
To probe changes on the molecular organization of lipid-
free apoAI after its interaction with LPS further, the
fluorescence properties of ANS were determined.
8-Anilino-1-naphthalenesulfonic acid is a dye whose
intrinsic fluorescence increases upon binding to a
hydrophobic surface or cavity.16 In the absence of
protein, ANS has a very low quantum yield with an
emission wavelength maximum at 515 nm (exc 395 nm).
The addition of apoAI induces an enhancement in ANS
fluorescence quantum yield (Fig. 3A). A significantly
higher fluorescence increase was observed when apoAI
was previously incubated with LPS (Fig. 3B), suggesting
that the relative amount of ANS-accessible hydrophobic
surface in the protein is increased by LPS interaction.
Controls of enhancement of ANS fluorescence due
to LPS were done. Any fluorescence increase was
observed, indicating that the large enhancement of
ANS fluorescence may be due to the looseness of the
apoAI conformation induced by LPS.
Resonance energy transfer between Trp residues and
ANS molecules has been reported, so energy transfer
efficiency was calculated from the decrease in donor
fluorescence for both free apoAI or after incubation of
apoAI with LPS (data not shown). Both results were
similar supporting the idea that LPS does not interact
with the N-terminal portion of apoAI, where most of the
Trp residues are located.
2.0(A)
(B)
1.5
1.0
Fl
uo
re
sc
en
ce
 in
te
ns
ity
Fl
uo
re
sc
en
ce
 in
te
ns
ity
0.5
0.0
2.0
1.5
1.0
0.5
0.0
400 420 440
0 mm ANS
5 mm ANS
20 mm ANS
50 mm ANS
100 mm ANS
460 480 500 520 540 560
400 420 440 460 480 500 520 540 560
Fig. 3. ANS binding experiments. Fluorescence spectra of ANS were
obtained in the presence of apoAI (A) or apoAI-LPS (1 : 2.8 molar ratio,
previously incubated) (B). Spectra were recorded for increasing ANS
concentrations (0–100 mM). Samples were excited at 295 nm with
emission monitored from 400–550 nm. Protein concentration in both
cases was 2.85mM.
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Fig. 2. Chemical modification of Trp with N-bromosuccinimide.
Intrinsic fluorescence of apoAI (filled circles) or apoAI after LPS
incubation (open circles) was measured after NBS addition. The Trp
emission spectra were recorded in the wavelength range 300–400 nm. Fo
and F represent the intrinsic fluorescence of native and oxidized protein,
respectively. Protein concentration used in both cases was 2.85mM.
ApoAI–LPS (1 : 2.8 molar ratio) were previously incubated for 15 min.
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Guanidinium hydrochloride denaturation
Denaturation curves are suitable for measuring differ-
ences in conformational stability among proteins. The
relative concentration of folded (native) and unfolded
conformations can be determined from studies in which
spectral probes such Trp, are used to monitor the
conformational state of the protein.29 The fluorescence
intensity of Trp decreases upon denaturation. Employing
the intensity value at 333 nm for each GdnHCl concen-
tration tested, it was possible to estimate fD (mole
fraction of denatured molecules) (Fig. 4A).
Guanidinium hydrochloride unfolding transitions
reached a plateau, and a two-model state fits the
experimental data. The GdnHCl concentration required
to reach the mid-point of the transition between both
states (Cm) was 1.4 for both apoAI in buffer and after its
interaction with LPS. However, as seen in Figure 4A, the
presence of LPS decreases the co-operativity of the
unfolding process.
Because the unfolding event consists of an equilib-
rium process involving two states, it allows the defini-
tion of the equilibrium constant K¼ fD/(1 fD). Hence,
the Gibb’s free energy (G) for the unfolding reaction
in terms of these mole fractions at a particular GdnHCl
concentration (G ¼RT ln K) can be calculated. The
dependence of G on GdnHCl concentration can be
approximated by the linear equation G ¼GH2O m
[GdnHCl], where the free energy of unfolding in the
absence of denaturant (G

H2O
), which represents the
conformational stability of the protein, can be obtained
by extrapolating to zero denaturant concentration. The
coefficient m is proportional to the amount of hydro-
phobic regions of the protein that are exposed to solvent
when the protein unfolds.30 Figure 4B shows thatG

H2O
and m change in the presence of LPS. G

H2O
decreases
from 3544 cal/mol to 1426 cal/mol and m also decreases
from 2207 to 937 for apoAI in buffer or after its
interaction with LPS, respectively.
Circular dichroism spectroscopy
Circular dichroism (CD) is a technique sensitive to the
chirality of the environment. The far-UV region of
proteins absorbance spectrum (190–250 nm) is domi-
nated by the electronic absorbance from peptide bonds
and provides information about the secondary structure
of a protein because each category of secondary struc-
ture (e.g. a-helix, b-sheet) has a different effect on the
chiral environment of the peptide bond. Far-UV CD
spectra recorded for lipid-free apoAI and after its
incubation with LPS are characteristic for an a-helix
structure with two negative bands at 222 and 208 nm and
a positive one at 193 nm as shown in Figure 5; therefore,
the presence of LPS does not modify the secondary
structure predominant in apoAI. At near-physiological
temperatures, the secondary structure of apoAI is char-
acterized by 55% helical content, as inferred from the
molar ellipticity at 222 nm, according to the litera-
ture.31,32 The helical content after LPS interaction
decreases to 46%. These results suggest that, in the
presence of LPS, unfolding of certain a-helix portions
occurs in some regions of the protein.
Cross-linking of 125I ASD–LPS to apoAI
In order to test if a direct interaction between LPS and
apoAI takes place, cross-linking procedures using
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Fig. 4. (A) Chemical denaturation of apoAI (filled circles) and apoAI-
LPS (open circles) at different GdnHCl concentrations (0–5.5 M) in buffer
A at pH 7.4, and 25C quantified from fluorescence intensity at 333 nm.
fD corresponds to molar fraction of denatured molecules and was
estimated as described in Materials and Methods. The excitation
wavelength was 295 nm. Data were fitted to sigmoidal curves using the
curve-fitting procedures in SigmaPlot (Jandel Scientific, San Rafael, CA,
USA). The black and gray lines correspond to apoAI and apoAI–LPS
denaturation curves, respectively. The protein concentration was 2.85mM
in both cases. (B) Dependence of the unfolding free energy (G) with
denaturant concentration for apoAI (filled black circles) and apoAI–LPS
(filled gray circles). m and G

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were calculated from the slope and
ordinate intercept, respectively.
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125I-ASD–LPS (described in Materials and Methods),
including UV irradiation, SDS-PAGE and autoradiogra-
phy, were done.
The N-hydroxysuccinimidyl derivative can easily
react with primary amines under the condition applied
for the coupling step (0.1 M borate buffer, pH 8.5). Since
core and O-polysaccharide glucosamine are both quan-
titatively acetylated, the more likely site for attachment
of this ASD compound is via an amide linkage to the
primary ethanolamine. Phosphoethanolamine serves as
the major attachment site for the ASD label on LPS.
Incorporation of 125I into apoAI could be detected as
seen in Figure 6, corroborating the direct interaction of
LPS with apoAI.
Chemical cleavage of apoAI-125I ASD–LPS with CNBr
In order to determine which portion of the protein
interacts with LPS, cleavage of apoAI-125I ASD–LPS
with CNBr was performed. The proteolytic fragments
were analyzed by tricine SDS-PAGE and autoradiogra-
phy yielded the results shown in Figure 7.
Apolipoprotein AI contains three methionine residues
at which cleavage with CNBr occurs: residues Met 86,
Met 112, and Met 148 and only four polypeptides should
be obtained by complete cleavage. However, because of
incomplete cleavage, a more complex pattern, of 8
peptide bands (A–H) can be observed (Fig. 7A).
Autoradiography analysis of the proteolytic products
obtained by CNBr cleavage (Fig. 7B) shows that five
peptides (B, C, E, F and H) are radioactively labeled. A
different label radioactivity can be observed in each
band, which is possibly due to differences in their
affinity to LPS.
As we focus our interest on the minimal portion of
apoAI able to bind LPS with high affinity, the
N-terminal sequence of fragments E, F and H
(Fig. 7B) were obtained. These fragments correspond
to segments from residues 113–148 (fragment E),
149–243 (fragment F) and 1–112 (fragment H).
However, because fragment F which correspond to the
C-terminal half of apoAI contains a higher label of
radioactivity, we chose this fragment to test the capa-
bility of endotoxin neutralization by measurement of
TNF-a release.
Tumor necrosis factor- release measurements
Tumor necrosis factor-a is one of the major cytokines
that is synthesized and secreted by macrophages upon
stimulation by LPS. The effect of apoAI and fragment F
on LPS induced TNF-a release was monitored by
ELISA. For these studies, fragment F was purified by
electroelution as described in Materials and Methods.
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Fig. 6. Cross-linking of 125I-ASD–LPS with apoAI. For cross-linking
experiments, 125I-ASD–LPS (5 mg) incubated with apoAI (1 : 2.8
protein : LPS molar ratio) were subjected to photolysis. Sodium dodecyl
sulfate-PAGE electrophoresis was carried out on 4–25% continuous
gradient gels (10 mg protein concentration). Proteins were stained with
Coomassie Blue (A) and subsequent autoradiography was performed on
Storm 840 (B). Lane 1, molecular mass markers; lane 2, apoAI standard;
lane 3, apoAI-125I-ASD–LPS interaction.
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Fig. 7. Chemical cleavage of apoAI-125I-ASD–LPS with CNBr. Apo
AI-125I-ASD–LPS cleavage with CNBr was analyzed by tricine SDS-
PAGE. The proteolytic fragments were stained with Coomasie Blue (A) and
exposed to X-Omat film (Kodak) for radioactive detection (B). The arrows
indicate the proteolytic fragments. Panel A: lane 1, CNBr proteolytic
fragments of apoAI-125I-ASD-LPS, lane 2, MWM (Pharmacia).
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Fig. 5. Circular dichroism spectra in the far-UV (190–250 nm) region
were collected for apoAI in the absence (black line) or presence (gray
line) of LPS. Protein concentration: 100 mg/ml. ApoAI–LPS were used in
1 : 2.8 (molar ratio).
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Stimulation of cells with LPS resulted in TNF-a
production, taken as 100%. Pre-incubation of LPS
(10 ng/ml) with both apoAI and fragment F, in two
different concentrations (protein/fragment F : LPS; 1 : 1
and 10 : 1, w/w), resulted in a reduction in the level of
TNF-a release by the cells (Fig. 8). A 58% and 15%
TNF-a release were observed in the presence of 1 : 1 w/w
and 10 : 1 w/w apoAI : LPS, respectively. In addition,
65% and 10% of TNF-a release were obtained when the
fragment F was assayed at of 1 : 1 w/w and 10 : 1 w/w
apoAI : LPS, respectively. The respective control with
apoAI and fragment F were done and subtracted in each
experiment.
DISCUSSION
Structural analysis of peptides that naturally bind LPS
can be helpful in identifying those molecular features
involved in binding to, and neutralizing, LPS.
Regardless of the molecular structure of a given peptide,
the underlying theme for efficient interaction with, and
binding to, LPS is known from many studies to be a net
positive charge and high hydrophobicity, usually in the
context of an amphipathic structure. Positively charged
residues from the peptide presumably promote interac-
tion with negatively charged groups on LPS, that is,
phosphates on the lipid A glucosamines and/or those in
the inner core polysaccharide unit; while hydrophobic
residues from the peptide interact with acyl chains on
lipid A.
Mature human apoAI contains 243 amino acid resi-
dues33 with 11-mer and 22-mer homologous repeats that
are predicted to form amphipathic a-helices that interact
with lipids through their hydrophobic face. The helices
are linked by short and flexible b-turns usually contain-
ing a proline residue. Lipid-free apoAI is thought to be a
bundle of helices.34
A high conformational flexibility in apoAI is needed
for its existence in different states – lipid-free, lipid-
poor, and discoidal or spherical lipoproteins of different
size. The conformational flexibility of apoAI could also
play a role in the interaction with LPS, in both lipid-free
and also in lipid-associated states.
Although there are no changes in the max of Trp
spectra of lipid-free apoAI after its interaction with LPS,
a decrease in the intrinsic fluorescence intensity is
observed (Fig. 1). This is due to a more relaxed structure
of apoAI–LPS complex, as suggested by the denatur-
ation behavior, with a higher water accessibility and also
by the presence of polar groups of the associated LPS.
The denaturation curves give important information
concerning protein stability in the free or LPS-associated
state. As seen in Figure 4, the interaction of LPS with
apoAI is responsible of a decreased co-operativity of the
unfolding process. As is known, molten globule proteins
typically unfold at low concentrations of denaturant and
do not show a sigmoidal unfolding curve. As a conse-
quence of the interaction of apoAI with LPS, the protein
is less stable, as was demonstrated by a lower G

H2O
value. G decreases more slowly with increasing
denaturant concentration in the presence of LPS in
comparison with lipid-free apoAI, as was expected, due
to the lower hydrophobic surface exposed during dena-
turation. This is due to a more relaxed structure of
apoAI–LPS complex and also because the presence of
polar groups of the associated LPS. These facts are also
reflected in lower m values in comparison with free
apoAI.
Apolipoprotein AI has been proposed to unfold and
bind lipids via a molten globule state.35 In our study, we
also found that apoAI–LPS complex presents a molten
globule-like behavior.
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Fig. 8. Tumor necrosis factor-a release (%) by RAW 264.7 cells after
incubation with LPS (10 ng/ml) (black bar) apoAI : LPS mixture (light
gray bar) and fragment F : LPS mixture (dark gray bar) at 1 : 1 w/w ratio
(A) and LPS (black bar) (10 ng/ml) and apoAI : LPS mixture (light gray
bar) and fragment F : LPS mixture (dark gray bar) at 1 : 1o w/w ratio (B).
Each experiment was done least three times, and the data were averaged.
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Experiments of Trp oxidation with NBS render the
same result independently, if the protein is in buffer or if
it was previously incubated with LPS. As a first
approach, it is possible to speculate that the N-terminal
half of the protein, where 3 of the 4 Trp amino-acid
residues are located, are not involved in the interaction
with LPS.
The cross-linking assay between apoAI and 125I-
ASD–LPS (Fig. 6) followed by chemical cleavage with
CNBr, gave a series of fragments which were analyzed
by tricine SDS-PAGE and autoradiography (Fig. 7).
These fragments were electroeluted and sequenced by
the Edman method, showing that the fragment contain-
ing the higher level of radioactivity corresponds to
N-terminal sequence RDRARA. According to the
molecular mass and the N-terminal sequence, the frag-
ment named ‘F’, corresponds to the C-terminal half of
apoAI (residues 148–243). Together, our results confirm
the hypothesis that the C-terminal half of apo-AI is
involved in the binding with LPS. For this reason, we
chose the fragment F of apoAI to test the capability of
neutralize endotoxic effect of LPS by TNF-a release
measurements. Pre-incubation of LPS (10 ng/ml) with
the C-terminal half of apoAI resulted in a reduction of
the TNF-a release by the cells in 90% in comparison
with the 85% observed for the LPS incubated with free
apoAI (Fig. 8). This result confirms the important role of
the C-terminal half of apoAI in the binding and neutral-
ization of the endotoxic effect of LPS.
The N-terminal half of apoAI (approximately amino-
acids 1–139) is highly a-helical and primarily respon-
sible for the stability of the protein in solution, while the
C-terminal half (approximately amino-acids 140–243) is
relatively unstable. Roberts et al.36 studied limited
proteolysis of lipid-free apoAI, and they found that the
C-terminal half (in their case, approximately amino-
acids 190–243) of lipid-free apoAI is highly susceptible
to proteolysis, whereas the N-terminus is less exposed.
From analysis of the cleavage patterns generated, a
model of lipid-free apoAI, consisting of a bundle of
a-helices in the N-terminal region with an unorganized
C-terminus was constructed.
Details of the conformation and lipid interaction of a
C-terminal 46-residue peptide, (198–243)apoAI, encom-
passing putative helix repeats 10 and 9 and the second
half of repeat 8 from the C-terminus of apoAI was
published by Zhu and Atkinson.37 Far-UV circular
dichroism spectra showed that (198–243)apoAI is also
unfolded in aqueous solution. They showed direct
evidence that the C-terminal peptide model can mimic
the interaction with the phospholipid of plasma apoAI to
form two sizes of homogeneous discoidal complexes.
A synthetic peptide containing amino-acids 220–241
of apoAI has been shown to have the highest affinity
toward lipids among the other apoAI helices. Supporting
evidence for the existence of a-helical structure in repeat
10 comes from the work of Palgunachari et al., who
showed that, among a series of synthetic peptides
corresponding to the helical repeats of apoAI, the
peptide encompassing residues 220–242 had the highest
a-helix content in solution, stability and lipid binding
potential of all the peptides studied.38
Segrest and colleagues39 proposed that the a-helices
of apolipoproteins are not all equivalent in their affinities
toward lipids. The differences in affinity do not appear to
be only related to their hydrophobic moment but also to
the distribution of charged residues along the axis of the
helix. Amphipathic helices are classified into seven
major and distinct classes (A, H, L, G, K, C, and M)
based upon a detailed analysis of their physicochemical
and structural properties. The most frequent helix class
found in exchangeable apolipoproteins is class A, which
is characterized by a unique clustering of positively
charged amino acid residues at the polar–non-polar
interface and negatively charged residues at the center of
the polar face. Six class A helices have been identified in
apoAI,40,41 three of which are in the N-terminal half of
apoAI (helices 44–65, 66–87, 121–142), and the other
three are in the C-terminal half (helices 143–164, 166–
186, and 187–208). In addition, two other helix types
were also identified: class G* (helix 8–33) and class Y
(helices 88–98, 99–120 in the N-terminal half of apoAI
and 209–219, and 220–241 in the C-terminal half of
apoAI). The basic feature of the class Y motif are two
negative residue clusters on the polar face separating the
two arms and the base of the Y motif formed by three
positive residue clusters. It was proposed that the lipid
affinity correlates with the extent to which a helix
domain fits to class A motif.40,42
Experiments using the hydrophobic reagent 3-(tri-
fluoromethyl)-3-(m-[125I]-iodophenyl-diazirine, demon-
strated the apoAI regions in contact with the lipid phase
in the rHDL discs. Two protein regions loosely bound to
lipids in HDL were detected – a C-terminal domain and a
central one located between residues 87 and 112. They
consist of class Y amphipathic a-helices.
While important functions have been attributed to the
C-terminal region of apoAI in initial binding to lipid43
and interaction with cells,44 little is known about its
involvement in LPS interaction. Our results show that
lipid-free apoAI can directly interact with LPS, and the
helical stretches along the protein are responsible for the
multiple regions able to interact with LPS, as seen in
Figure 7B, by the multiple fragments radiolabeled after
photochemical cross-linking.
According to our previous results about the partition
of LPS in lipid membranes (Henning et al., unpublished
results), we suggest that, when the protein is associated
with lipid such as in HDL particles, partition of LPS in
the lipid matrix of the lipoprotein could favor the
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interaction between the lipid-binding domain of apoAI,
which is exposed to the lipid matrix of HDL, and LPS.
On the other hand, according to Corsico et al.,45 the
C-terminal half of the protein presents a loose region
capable of binding membrane lipids, and taking into
account that this region is the one that we found to
interact with LPS, we can speculate that the same region
involved in the interaction with lipids is involved in the
interaction with LPS.
CONCLUSIONS
The C-terminal half of apoAI may be involved in LPS
interaction in both lipid-free conditions or when the
protein is associated with lipid in HDL. The results of
this research suggest that the C-terminal half of apoAI
presents beneficial anti-inflammatory effects. Peptides
derived from this part of apoAI molecule have great
potential as a therapeutic agent in inflammatory
diseases.
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